•AbbVie received European Commission marketing authorization for TEPKINLY in combination with other drugs for relapsed or refractory follicular lymphoma.
•Consensys announced that the U.S. Securities and Exchange Commission (SEC) has closed its investigation into Ethereum 2.0 without recommending any enforcement action.